Skip to main
BWAY

Brainsway (BWAY) Stock Forecast & Price Target

Brainsway (BWAY) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BrainsWay is a domain leader in transcranial magnetic stimulation, PBWAY has demonstrated their ability to optimize profitability through recurring revenue streams, this is expected to continue as their pipeline expands and reimbursement options grow; securing a whopping $78.5M in revenue in the past 12-month period, BrainsWay's total firm value is evaluated at ~$800M using a 5.6x sales multiple. There are limited risks to BrainsWay's growth and valuation as the company has a strong foundation in the market, a diverse pipeline, and multiple treatment options for various indications.

Bears say

BrainsWay is set to face challenges as it aims to expand its Deep TMS technology beyond its current indications and into new patient populations, as evidenced by its publication of a pilot study for the use of Deep TMS in patients with MDD and co-occurring early-stage Alzheimer's disease. While the results of this study showed promising results in both clinical outcomes and brain activity changes, it was conducted on a small sample size, and further trials would be necessary to support label expansion. Additionally, slower than projected uptake of Deep TMS systems, failure to expand reimbursement and market access, and potential long-term dilution risks could pose challenges for the company's growth and achievement of its $19 per share price target.

Brainsway (BWAY) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Brainsway and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Brainsway (BWAY) Forecast

Analysts have given Brainsway (BWAY) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Brainsway (BWAY) has a Strong Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Brainsway (BWAY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.